Who are the key players in the Shingrix (Zostavax) Market Report 2026 market?

Major companies operating in the Shingrix (Zostavax) Market Report 2026 market are Major companies operating in the shingrix (zostavax) market are GSK plc Read More

What are the major opportunities in the Shingrix (Zostavax) market? What are the strategies for the Shingrix (Zostavax) market?

For detailed insights on the major opportunities and strategies in the Shingrix (Zostavax) market, Read More

How does the Shingrix (Zostavax) market relate to the overall economy and other similar markets?

For detailed insights on Shingrix (Zostavax)'s relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Shingrix (Zostavax) market growth? SWOT analysis of the Shingrix (Zostavax) market.

For detailed insights on the key dynamics influencing the Shingrix (Zostavax) market growth and SWOT analysis of the Shingrix (Zostavax) industry, Read More

Shingrix (Zostavax) Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Shingrix (Zostavax) Market Report 2026

Name: Shingrix (Zostavax) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Shingrix (Zostavax) Market Overview

• The Shingrix (Zostavax) market growth in the historic period has been driven by increasing awareness of shingles complications, aging global population growth

• Market expansion is supported by increasing adult vaccination coverage targets, rising healthcare spending on preventive care

• Growth Driver: Growing Adoption Of Vaccination Drives The Market Growth

• Market Trend: Innovative Non-Live, Recombinant Subunit Vaccines Enhance Market Growth

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Shingrix (Zostavax) Market?

Shingrix (Zostavax) refers to a vaccine designed to prevent shingles (herpes zoster), a painful rash caused by the reactivation of the varicella-zoster virus. It is used for immunizing adults, particularly those aged 50 and older, to reduce the risk of developing shingles and its complications.

The main types of formulation in shingrix (zostavax) are recombinant vaccines (shingrix) and live-attenuated vaccines (zostavax). Recombinant vaccine (shingrix) refers to a non-live vaccine developed using recombinant DNA technology to prevent shingles, which stimulates the immune system by introducing a protein from the varicella-zoster virus, providing strong protection against the disease. The indications include shingles prevention and post-herpetic neuralgia with distribution channels such as hospital pharmacy and retail pharmacy.

Shingrix (Zostavax) Market Global Report 2026 Market Report bar graph

What Is The Shingrix (Zostavax) Market Size and Share 2026?

The growth in the historic period can be attributed to increasing awareness of shingles complications, aging global population growth, prior limitations of live attenuated vaccines, expansion of immunization guidelines for older adults, increasing physician recommendation rates.

What Is The Shingrix (Zostavax) Market Growth Forecast?

The growth in the forecast period can be attributed to increasing adult vaccination coverage targets, rising healthcare spending on preventive care, expansion of recombinant vaccine pipelines, growing government-supported immunization initiatives, increasing focus on reducing post-herpetic neuralgia burden. Major trends in the forecast period include increasing adoption of recombinant vaccine platforms, rising focus on adult immunization programs, growing demand for long-lasting shingles protection, expansion of cold-chain optimized vaccine distribution, enhanced emphasis on vaccine safety and efficacy.

Book your 30 minutes free consultation with our research experts

Global Shingrix (Zostavax) Market Segmentation

1) By Formulation: Recombinant Vaccine (Shingrix), Live Attenuated Vaccine (Zostavax)

2) By Indication: Shingles Prevention, Post-Herpetic Neuralgia

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

What Is The Driver Of The Shingrix (Zostavax) Market?

The growing adoption of vaccination is expected to propel the growth of the shingrix (zostavax) market going forward. Vaccination refers to the process of administering a vaccine to stimulate the body's immune system to recognize and fight specific pathogens. The growing adoption of vaccination is attributed to increased awareness of its effectiveness in preventing diseases, reducing disease burden, and the development of safe and accessible vaccines. Public health campaigns, improved healthcare infrastructure, and global vaccination initiatives also contribute to its widespread acceptance. Shingrix (Zostavax) is beneficial for vaccination by providing effective protection against shingles and its complications. It is particularly beneficial for adults over 50, significantly reducing the risk of shingles recurrence and post-herpetic neuralgia. For instance, in May 2024, according to a study published by the Journal of the American Medical Association (JAMA), a US-based peer-reviewed medical journal, the shingles vaccinations covered by Medicare Part D increased by 46% in the year following the IRA policy's implementation in January 2023. Therefore, the growing adoption of vaccination is driving the growth of the shingrix (zostavax) industry.

Key Players In The Global Shingrix (Zostavax) Market

Major companies operating in the shingrix (zostavax) market are GSK plc

Global Shingrix (Zostavax) Market Trends and Insights

Major companies operating in the shingrix (zostavax) market are focusing on developing innovative solutions, such as non-live, recombinant subunit adjuvanted vaccines, to meet the rising demand for safer and more effective immunization, especially driven by age-related immune decline and the need for options in immunocompromised populations. A non-live, recombinant subunit adjuvanted vaccine contains specific protein components (antigens) of a pathogen, combined with an adjuvant to boost the immune response, unlike traditional live-attenuated vaccines that use weakened forms of the whole virus. For instance, in 2023, GSK plc, a UK-based biopharmaceutical company, launched Shingrix (Recombinant Zoster Vaccine, RZV) in India. This vaccine is non-live, given intramuscularly in two doses, and consists of the glycoprotein E antigen plus GSK’s proprietary AS01B adjuvant system. Shingrix stimulates a strong and durable immune response, overcoming the decline in immunity in older adults, and offers very high efficacy (up to ~97%).

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Shingrix (Zostavax) Market?

In October 2023, Chongqing Zhifei, a China-based biotechnology company that specializes in the development, manufacturing, and distribution of vaccines, partnered with GSK plc. With this partnership, GSK plc aims to expand the market reach of its top-selling shingles vaccine, shingrix, in China, the world’s second-largest pharmaceutical market, by spending. GSK plc, a UK-based pharmaceutical industry company that manufactures shingrix (zoster vaccine recombinant).

Regional Insights

North America was the largest region in the shingrix (zostavax) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Shingrix (Zostavax) Market?

The shingrix (zostavax) market consists of sales of single-dose vials and pre-filled syringes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Shingrix (Zostavax) Market Report 2026?

The shingrix (zostavax) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the shingrix (zostavax) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Shingrix (Zostavax) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	No CAGR found from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Formulation, Indication, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	GSK plc
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Shingrix (Zostavax) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Shingrix (Zostavax) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Shingrix (Zostavax) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Shingrix (Zostavax) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Recombinant Vaccine Platforms

4.2.2 Rising Focus On Adult Immunization Programs

4.2.3 Growing Demand For Long-Lasting Shingles Protection

4.2.4 Expansion Of Cold-Chain Optimized Vaccine Distribution

4.2.5 Enhanced Emphasis On Vaccine Safety And Efficacy

5. Shingrix (Zostavax) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Immunization Centers

5.4 Retail Pharmacies

5.5 Public Health Organizations

6. Shingrix (Zostavax) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Shingrix (Zostavax) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Shingrix (Zostavax) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Shingrix (Zostavax) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Shingrix (Zostavax) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Shingrix (Zostavax) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Shingrix (Zostavax) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Shingrix (Zostavax) Market Segmentation

9.1. Global Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Recombinant Vaccine (Shingrix), Live Attenuated Vaccine (Zostavax)

9.2. Global Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Shingles Prevention, Post-Herpetic Neuralgia

9.3. Global Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacy

10. Shingrix (Zostavax) Market Regional And Country Analysis

10.1. Global Shingrix (Zostavax) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Shingrix (Zostavax) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Shingrix (Zostavax) Market

11.1. Asia-Pacific Shingrix (Zostavax) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Shingrix (Zostavax) Market

12.1. China Shingrix (Zostavax) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Shingrix (Zostavax) Market

13.1. India Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Shingrix (Zostavax) Market

14.1. Japan Shingrix (Zostavax) Market Overview

14.2. Japan Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Shingrix (Zostavax) Market

15.1. Australia Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Shingrix (Zostavax) Market

16.1. South Korea Shingrix (Zostavax) Market Overview

16.2. South Korea Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Shingrix (Zostavax) Market

17.1. Western Europe Shingrix (Zostavax) Market Overview

17.2. Western Europe Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Shingrix (Zostavax) Market

18.1. UK Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Shingrix (Zostavax) Market

19.1. Germany Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Shingrix (Zostavax) Market

20.1. France Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Shingrix (Zostavax) Market

21.1. Eastern Europe Shingrix (Zostavax) Market Overview

21.2. Eastern Europe Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Shingrix (Zostavax) Market

22.1. North America Shingrix (Zostavax) Market Overview

22.2. North America Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Shingrix (Zostavax) Market

23.1. USA Shingrix (Zostavax) Market Overview

23.2. USA Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Shingrix (Zostavax) Market

24.1. Canada Shingrix (Zostavax) Market Overview

24.2. Canada Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Shingrix (Zostavax) Market

25.1. South America Shingrix (Zostavax) Market Overview

25.2. South America Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Shingrix (Zostavax) Market

26.1. Middle East Shingrix (Zostavax) Market Overview

26.2. Middle East Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Shingrix (Zostavax) Market

27.1. Africa Shingrix (Zostavax) Market Overview

27.2. Africa Shingrix (Zostavax) Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Shingrix (Zostavax) Market Regulatory and Investment Landscape

29. Shingrix (Zostavax) Market Competitive Landscape And Company Profiles

29.1. Shingrix (Zostavax) Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Shingrix (Zostavax) Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Shingrix (Zostavax) Market Company Profiles

29.3.1. GSK plc Overview, Products and Services, Strategy and Financial Analysis

30. Global Shingrix (Zostavax) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Shingrix (Zostavax) Market

32. Shingrix (Zostavax) Market High Potential Countries, Segments and Strategies

32.1 Shingrix (Zostavax) Market In 2030 - Countries Offering Most New Opportunities

32.2 Shingrix (Zostavax) Market In 2030 - Segments Offering Most New Opportunities

32.3 Shingrix (Zostavax) Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Shingrix (Zostavax) Market, Overview Of Key Products - Product Examples

Table 2: Global Shingrix (Zostavax) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Shingrix (Zostavax) Market, Supply Chain Analysis

Table 4: Global Shingrix (Zostavax) Market, Major Raw Material Providers

Table 5: Global Shingrix (Zostavax) Market, Major Resource Providers

Table 6: Global Shingrix (Zostavax) Market, Major Manufacturers (Suppliers)

Table 7: Global Shingrix (Zostavax) Market, Major Distributors And Channel Partners

Table 8: Global Shingrix (Zostavax) Market, Key Technologies & Future Trends

Table 9: Global Shingrix (Zostavax) Market, Major Trends

Table 10: Global Shingrix (Zostavax) Market, Major End Users

Table 11: Global Shingrix (Zostavax) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Shingrix (Zostavax) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Shingrix (Zostavax) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Shingrix (Zostavax) Market - TAM, US$ Billion, 2025

Table 15: Global Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Shingrix (Zostavax) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Shingrix (Zostavax) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Shingrix (Zostavax) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Shingrix (Zostavax) Market - Company Scoring Matrix

Table 73: GSK plc Financial Performance

Table 74: Global Shingrix (Zostavax) Market, Competitive Benchmarking (In USD Billions)

Table 75: Global Shingrix (Zostavax) Market, Competitive Dashboard

Table 76: Global Shingrix (Zostavax) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 77: Global, Shingrix (Zostavax) Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030

Table 78: Global, Shingrix (Zostavax) Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Table 79: Global, Shingrix (Zostavax) Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Shingrix (Zostavax) Market, Overview Of Key Products - Product Examples

Figure 2: Global Shingrix (Zostavax) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Shingrix (Zostavax) Market, Supply Chain Analysis

Figure 4: Global Shingrix (Zostavax) Market, Major Raw Material Providers

Figure 5: Global Shingrix (Zostavax) Market, Major Resource Providers

Figure 6: Global Shingrix (Zostavax) Market, Major Manufacturers (Suppliers)

Figure 7: Global Shingrix (Zostavax) Market, Major Distributors And Channel Partners

Figure 8: Global Shingrix (Zostavax) Market, Key Technologies & Future Trends

Figure 9: Global Shingrix (Zostavax) Market, Major Trends

Figure 10: Global Shingrix (Zostavax) Market, Major End Users

Figure 11: Global Shingrix (Zostavax) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Shingrix (Zostavax) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Shingrix (Zostavax) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Shingrix (Zostavax) Market - TAM, US$ Billion, 2025

Figure 15: Global Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Shingrix (Zostavax) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Shingrix (Zostavax) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Shingrix (Zostavax) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Shingrix (Zostavax) Market - Company Scoring Matrix

Figure 73: GSK plc Financial Performance

Figure 74: Global Shingrix (Zostavax) Market, Competitive Benchmarking (In USD Billions)

Figure 75: Global Shingrix (Zostavax) Market, Competitive Dashboard

Figure 76: Global Shingrix (Zostavax) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 77: Global, Shingrix (Zostavax) Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030

Figure 78: Global, Shingrix (Zostavax) Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Figure 79: Global, Shingrix (Zostavax) Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Feed Premix Market Report 2026 - Global Outlook – By Type (Amino Acids, Antioxidants, Antibiotics, Vitamins, Minerals, Other Types), By Form (Dry, Liquid), By Livestock (Ruminants, Swine, Aquatic Animals, Poultry, Pets) ...

Zinc Battery Market Report 2026 - Global Outlook – By Type ( Zinc-Air Battery, Nickel-Zinc Battery, Zinc-Silver Battery, Carbon-Zinc Battery, Zinc-Manganese Battery, Other Types), By Rechargeability ( Primary, Secondary)...

Vertical Market Software Market Report 2026 - Global Outlook – By Software Type (Banking Software, Education Software, Legal Software, Agriculture Software, Alumni Management Software, Amusement Park Software, Apparel So...

Zinc Market Report 2026 - Global Outlook – By Product Type (Zinc Metal, Zinc Oxide, Zinc Sulfate, Zinc Chemicals And Alloys, Other Zinc Compounds), By Mining Type (Underground Mining, Surface Mining), By Application (Con...

Data Lake Market Report 2026 - Global Outlook – By Type (Solution, Services), By Deployment (On-Premise, Cloud), By Organization Size (Large Enterprises, Small And Medium-Sized Enterprises (SMEs)), By Vertical (Informati...

Zinc Citrate Market Report 2026 - Global Outlook – By Type (Dihydrate, Trihydrate), By Form (Granules, Powder), By Application (Personal Care, Health Care, Food and Beverage, Other Applications) – Market Size, Trends, St...

Next-Generation Solar Cell Market Report 2026 - Global Outlook – By Type (On-Grid, Off-Grid), By Material Type (Transceivers, Cadmium Telluride (CdTe), Copper Indium Gallium Selenide (CIGS), Amorphous Silicon (A-Si), Gal...

Frequently Asked Questions

How big is the Shingrix (Zostavax) Market?

The Shingrix (Zostavax) market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Shingrix (Zostavax) market growth?

The global Shingrix (Zostavax) market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Shingrix (Zostavax) market?

Some Key Players in the Shingrix (Zostavax) market Include, GSK plc .

What is the anticipated growth trend for the Shingrix (Zostavax) market?

Major trend in this market includes: Innovative Non-Live, Recombinant Subunit Vaccines Enhance Market Growth. For further insights on this market. request a sample here

Which region has the most growth potential in the Shingrix (Zostavax) market?

North America was the largest region in the shingrix (zostavax) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the shingrix (zostavax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.